Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance

Abstract

Colorectal cancer (CRC) is characterized by recurrent mutations deregulating key cell signaling cascades and providing the cancer cells with novel functional traits. Among the most frequent mutations in CRC are gain-of-function missense mutations in KRAS and BRAF. Oncogenic activation of KRAS and BRAF is mutually exclusive and occurs in approximately 40… (More)

5 Figures and Tables

Topics

Statistics

020406020162017
Citations per Year

Citation Velocity: 23

Averaging 23 citations per year over the last 2 years.

Learn more about how we calculate this metric in our FAQ.
  • Presentations referencing similar topics